Lung Disease News and Research

RSS

New safety guideline released for prescribing biological therapies in inflammatory arthritis

The British Society for Rheumatology publishes its latest clinical guideline in Rheumatology, the UK’s key specialist journal in the sector. The new guideline updates and presents two previous guidelines into one set of evidence based recommendations on the vital safety aspects of prescribing biological therapies in inflammatory arthritis.

28 Aug 2018

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance has initiated a pivotal clinical trial, SimpliciTB, that will evaluate whether a new four-drug regimen can treat most types of tuberculosis including multidrug-resistant TB more quickly and effectively than currently-available treatments.

28 Aug 2018

Use of medication reminder apps increases people's adherence to cardiovascular medication

We use them for everything from banking to workouts, and now research from the University of Sydney shows mobile apps could potentially save lives by helping people with coronary heart disease keep on top of their medication.

27 Aug 2018

UAB receives NIH grant to continue evaluation of new medication for IPF

The University of Alabama at Birmingham has received a grant from the National Institutes of Health totaling $8.9 million to fund a multiyear program evaluating the role of a new medication in a clinical trial for patients suffering from idiopathic pulmonary fibrosis

24 Aug 2018

Daily e-cigarette use could double the risk of heart attacks

Use of e-cigarettes every day can nearly double the odds of a heart attack, according to a new analysis of a survey of nearly 70,000 people, led by researchers at UC San Francisco.

22 Aug 2018

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Dr. Lesley Ann Saketkoo, an associate professor of clinical medicine at Tulane University School of Medicine, has been named Doctor of the Year by the Scleroderma Foundation. The award recognizes leadership and commitment to the community battling scleroderma, a disabling and life-limiting multi-organ autoimmune disease with progressive lung, heart, kidney, gastrointestinal tract and/or vascular involvement.

21 Aug 2018

Passive smoking exposure among kids greatly increases COPD risk late in life

According to the latest research adults who do not smoke are at a greater risk of dying of serious lung disorders if they grew up around parents who smoked. The study appeared in the latest issue of the journal American Journal of Preventive Medicine.

20 Aug 2018

Hospitals battle for control over fast-growing heart-valve procedure

When Medicare in 2011 agreed to pay for a revolutionary procedure to replace leaky heart valves by snaking a synthetic replacement up through blood vessels, the goal was to offer relief to the tens of thousands of patients too frail to endure open-heart surgery, the gold standard.

17 Aug 2018

Study finds rise in cases of progressive massive fibrosis among U.S. coal miners

The number of cases of progressive massive fibrosis (PMF) among U.S. coal miners has risen during the past two decades, even as the number of coal miners has declined, according to new research published online in the Annals of the American Thoracic Society.

17 Aug 2018

Statins may improve conditions of people with rare lung disease

In the first study of its kind, researchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition.

17 Aug 2018

Seeking solutions to treat scleroderma

It begins with cold hands. Not just put-on-some-gloves cold. Instead, the fingers overreact to cold by turning white or blue and may become numb or tingly.

17 Aug 2018

Penn researchers develop first mouse model of idiopathic pulmonary fibrosis

The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability to fully model the disease in animals, limiting the ability to observe and understand the disease.

16 Aug 2018

New digital pharmacy aims to help people living with chronic care conditions

Thirty jobs are to be created through a new £1.5m ‘Tele-Pharmacy’opening in Liverpool, aimed at helping people living with chronic care conditions to manage their medicinal needs through the UK’s only artificial intelligent mobile app ‘Now Patient’.

From Infohealth Ltd 14 Aug 2018

Scientists uncover mechanisms responsible for development of fibrosis

Idiopathic pulmonary fibrosis is an incurable lung disease of unknown origin with limited treatment options. Research suggests that the signaling molecule WNT5A plays a key role in the pathogenic process.

10 Aug 2018

Obesity in PTSD patients accounts for increased risk of type 2 diabetes mellitus

Saint Louis University research finds post-traumatic stress disorder does not directly lead to type 2 diabetes mellitus, instead obesity in PTSD patients accounts for the increased risk.

10 Aug 2018

Scientists identify drug that could reverse pulmonary arterial hypertension

Scientists at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago took a major step toward developing a new treatment for pulmonary arterial hypertension, a severe lung disease with a five-year survival rate of 50 percent.

9 Aug 2018

Breathing ‘a chore’: California wildfires threaten the health of young and old

Debbie Dobrosky noticed a peculiar hue in the sky on Monday — "a very ugly yellow casting" — as she peeked outside. A large cloud of smoke had begun to cover the sun.

8 Aug 2018

Study: People exposed to even low level of air pollution have serious changes in heart

Researchers have found that people exposed to air pollution levels well within UK guidelines have changes in the structure of the heart, similar to those seen in the early stages of heart failure.

3 Aug 2018

Mologic begins clinical trial to evaluate urine-based diagnostic for cystic fibrosis

Mologic Ltd, a developer of powerful, personalized diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company's urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis patients.

2 Aug 2018

RBC-hitchhiking method increases concentration of drugs ferried to selected organs

A new drug-delivery technology which uses red blood cells to shuttle nano-scale drug carriers, called RBC-hitchhiking, has been found in animal models to dramatically increase the concentration of drugs ferried precisely to selected organs, according to a study published in Nature Communications this month by researchers from the Perelman School of Medicine at the University of Pennsylvania.

2 Aug 2018

Lung Disease News and Research

New safety guideline released for prescribing biological therapies in inflammatory arthritis

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

Use of medication reminder apps increases people's adherence to cardiovascular medication

UAB receives NIH grant to continue evaluation of new medication for IPF

Daily e-cigarette use could double the risk of heart attacks

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Passive smoking exposure among kids greatly increases COPD risk late in life

Hospitals battle for control over fast-growing heart-valve procedure

Study finds rise in cases of progressive massive fibrosis among U.S. coal miners

Statins may improve conditions of people with rare lung disease

Seeking solutions to treat scleroderma

Penn researchers develop first mouse model of idiopathic pulmonary fibrosis

New digital pharmacy aims to help people living with chronic care conditions

Scientists uncover mechanisms responsible for development of fibrosis

Obesity in PTSD patients accounts for increased risk of type 2 diabetes mellitus

Scientists identify drug that could reverse pulmonary arterial hypertension

Breathing ‘a chore’: California wildfires threaten the health of young and old

Study: People exposed to even low level of air pollution have serious changes in heart

Mologic begins clinical trial to evaluate urine-based diagnostic for cystic fibrosis

RBC-hitchhiking method increases concentration of drugs ferried to selected organs

The ultimate guide to lung research tools and protocols eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News